Agency Information Collection Activities; Proposed eCollection eComments Requested; Drug Use Statement, 78336-78337 [2024-21939]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 78336 Federal Register / Vol. 89, No. 186 / Wednesday, September 25, 2024 / Notices Court to ‘‘construct [its] own hypothetical case and then evaluate the decree against that case.’’ Microsoft, 56 F.3d at 1459; see also U.S. Airways, 38 F. Supp. 3d at 75 (noting that the court must simply determine whether there is a factual foundation for the government’s decisions such that its conclusions regarding the proposed settlements are reasonable); InBev, 2009 U.S. Dist. LEXIS 84787, at *20 (‘‘[T]he ‘public interest’ is not to be measured by comparing the violations alleged in the complaint against those the court believes could have, or even should have, been alleged.’’). Because the ‘‘court’s authority to review the decree depends entirely on the government’s exercising its prosecutorial discretion by bringing a case in the first place,’’ it follows that ‘‘the court is only authorized to review the decree itself,’’ and not to ‘‘effectively redraft the complaint’’ to inquire into other matters that the United States did not pursue. Microsoft, 56 F.3d at 1459–60. In its 2004 amendments to the APPA, Congress made clear its intent to preserve the practical benefits of using judgments proposed by the United States in antitrust enforcement, Pub. L. 108–237 § 221, and added the unambiguous instruction that ‘‘[n]othing in this section shall be construed to require the court to conduct an evidentiary hearing or to require the court to permit anyone to intervene.’’ 15 U.S.C. 16(e)(2); see also U.S. Airways, 38 F. Supp. 3d at 76 (indicating that a court is not required to hold an evidentiary hearing or to permit intervenors as part of its review under the Tunney Act). This language explicitly wrote into the statute what Congress intended when it first enacted the Tunney Act in 1974. As Senator Tunney explained: ‘‘[t]he court is nowhere compelled to go to trial or to engage in extended proceedings which might have the effect of vitiating the benefits of prompt and less costly settlement through the consent decree process.’’ 119 Cong. Rec. 24,598 (1973) (statement of Sen. Tunney). ‘‘A court can make its public interest determination based on the competitive impact statement and response to public comments alone.’’ U.S. Airways, 38 F. Supp. 3d at 76 (citing Enova Corp., 107 F. Supp. 2d at 17). VIII. Determinative Documents There are no determinative materials or documents within the meaning of the APPA that were considered by the United States in formulating the proposed Final Judgment. Dated: September 18, 2024. VerDate Sep<11>2014 17:28 Sep 24, 2024 Jkt 262001 Respectfully submitted, lllllllllllllllllllll Kenneth A. Libby, Special Attorney, U.S. Department of Justice, Antitrust Division, c/o Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC 20580, Phone: (202) 326– 2694, Email: klibby@ftc.gov. [FR Doc. 2024–21943 Filed 9–24–24; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1410] Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 25, 2024. Such persons may also file a written request for a hearing on the application on or before October 25, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should DATES: Frm 00058 Fmt 4703 Controlled substance Drug code Ecgonine ................. Importer of Controlled Substances Application: Curium US LLC PO 00000 also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on July 4, 2024, Curium US LLC, 2703 Wagner Place, Maryland Heights, Missouri 63043–3421, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Sfmt 4703 9180 Schedule II The company plans to import small quantities of a derivative form of the listed controlled substance to be used for manufacturing purposes. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Marsha L. Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–21850 Filed 9–24–24; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0NEW] Agency Information Collection Activities; Proposed eCollection eComments Requested; Drug Use Statement Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until October 19, 2024. FOR FURTHER INFORMATION CONTACT: If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions SUMMARY: E:\FR\FM\25SEN1.SGM 25SEN1 ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 186 / Wednesday, September 25, 2024 / Notices or additional information, please contact Kannessia Jordan, Section Chief, Office of Compliance, Policy Administration Section 700 Army Navy Drive, Arlington, VA 22202, telephone: 571–776–2262, email: Kannessia.S.Jordan@DEA.gov. SUPPLEMENTARY INFORMATION: The proposed information collection was previously published in the Federal Register on July 19, 2024, allowing a 60day comment period. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and/or —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Written comments and recommendations for this information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the information collection or the OMB Control Number [OMB 1117–0043]. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view Department of Justice, information collections currently under review by OMB. DOJ seeks PRA authorization for this information collection for three (3) years. OMB authorization for an ICR cannot be for more than three (3) years without renewal. The DOJ notes that information collection requirements submitted to the OMB for existing ICRs receive a month-to-month extension while they undergo review. VerDate Sep<11>2014 17:28 Sep 24, 2024 Jkt 262001 78337 Overview of This Information Collection Data Access Program’’ to read ‘‘Secure Transfer, Restricted-Use Data Lake’’. 1. Type of Information Collection: Revision. 2. Title of the Form/Collection: Drug Enforcement Administration PreEmployment Drug Policy Notification and Acknowledgement. 3. Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form number: DEA–200. The sponsoring component is the Drug Enforcement Administration. 4. Affected public who will be asked or required to respond, as well as a brief abstract: DEA job applicants are asked to complete the form. While not mandatory, an applicant can be disqualified in the hiring process for failing to provide the requested acknowledgement. 5. Obligation to Respond: Mandatory DEA Pre-Employment Drug Policy. 6. Total Estimated Number of Respondents: 4,727. 7. Estimated Time per Respondent: 7 minutes. 8. Frequency: 1. 9. Total Estimated Annual Time Burden: 551 hours. 10. Total Estimated Annual Other Costs Burden: $0. If additional information is required, contact: Darwin Arceo, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 4W–218, Washington, DC 20530. Alix Gould-Werth, Chief Evaluation Officer, U.S. Department of Labor. Dated: September 20, 2024. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2024–21939 Filed 9–24–24; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR [OMB Control No. 1290–0NEW] Department of Labor’s Restricted Use Data Access Program; Correction Office of the Assistant Secretary for Policy, Chief Evaluation Office, Department of Labor. ACTION: Correction. AGENCY: In the Federal Register of August 24, 2023, in notice document 2023–18234 on page 57975, make the following correction: In the subject line correct ‘‘Department of Labor’s Restricted Use SUMMARY: PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 [FR Doc. 2024–21637 Filed 9–24–24; 8:45 am] BILLING CODE 4510–HX–P MILLENNIUM CHALLENGE CORPORATION [MCC FR 24–07] Millennium Challenge Corporation Selection Criteria and Methodology Report for Fiscal Year 2025 Millennium Challenge Corporation. ACTION: Notice. AGENCY: The Millennium Challenge Act of 2003, as amended, requires the Millennium Challenge Corporation to publish a report that identifies the criteria and methodology that MCC intends to use to determine which candidate countries may be eligible to be considered for assistance under the Millennium Challenge Act for fiscal year 2025. The report is set forth in full below. SUMMARY: (Authority: 22 U.S.C. 7707(b)(2)) Dated: September 20, 2024. Peter E. Jaffe, Vice President, General Counsel, and Corporate Secretary. Millennium Challenge Corporation Selection Criteria and Methodology Report for Fiscal Year 2025 This document explains how the Board of Directors (the Board) of the Millennium Challenge Corporation (MCC) will identify, evaluate, and select eligible countries for fiscal year (FY) 2025. Specifically, this document discusses the following: (I) Which countries MCC will evaluate (II) How the Board evaluates these countries A. Overall evaluation B. For selection of an eligible country for a first compact C. For selection of an eligible country for a subsequent compact D. For selection of an eligible country for a concurrent compact E. For threshold program assistance F. A note on potential transition out of MCC’s candidate pool after initial selection This report is provided in accordance with section 608(b) of the Millennium Challenge Act of 2003, as amended (the Act), as more fully described in Appendix A. E:\FR\FM\25SEN1.SGM 25SEN1

Agencies

[Federal Register Volume 89, Number 186 (Wednesday, September 25, 2024)]
[Notices]
[Pages 78336-78337]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21939]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0NEW]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Drug Use Statement

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration, Department of Justice 
(DOJ), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995.

DATES: Comments are encouraged and will be accepted for 30 days until 
October 19, 2024.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions

[[Page 78337]]

or additional information, please contact Kannessia Jordan, Section 
Chief, Office of Compliance, Policy Administration Section 700 Army 
Navy Drive, Arlington, VA 22202, telephone: 571-776-2262, email: 
[email protected].

SUPPLEMENTARY INFORMATION: The proposed information collection was 
previously published in the Federal Register on July 19, 2024, allowing 
a 60-day comment period. Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website www.reginfo.gov/public/do/PRAMain. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number [OMB 1117-0043]. This information collection 
request may be viewed at www.reginfo.gov. Follow the instructions to 
view Department of Justice, information collections currently under 
review by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection

    1. Type of Information Collection: Revision.
    2. Title of the Form/Collection: Drug Enforcement Administration 
Pre-Employment Drug Policy Notification and Acknowledgement.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Form number: DEA-200. 
The sponsoring component is the Drug Enforcement Administration.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract: DEA job applicants are asked to complete the 
form. While not mandatory, an applicant can be disqualified in the 
hiring process for failing to provide the requested acknowledgement.
    5. Obligation to Respond: Mandatory DEA Pre-Employment Drug Policy.
    6. Total Estimated Number of Respondents: 4,727.
    7. Estimated Time per Respondent: 7 minutes.
    8. Frequency: 1.
    9. Total Estimated Annual Time Burden: 551 hours.
    10. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.

    Dated: September 20, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-21939 Filed 9-24-24; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.